A discovery about prostate cancer could cut 10 years off of research.
Androgens, the male sex hormones, fuel the growth of prostate cancer. Cancer growth can be slowed by reducing the amounts of these hormones.
Metastatic prostate cancer has been successfully treated with hormone treatment. Prostate cancer patients who have spread to other parts of their bodies may benefit from anti-hormonal therapy, which works by blocking the signal that testosterone sends to the tumor.
There is a chance that tumor cells will eventually become resistant to this treatment. Scientists from the Netherlands Cancer Institute and other institutions across the world have now disclosed an "unexpected potential" approach that aims to regulate the circadian cycle of cells rather than combat cancer.
Cancer Discovery released the findings on Monday.
Anti-hormonal therapy-m...